Timothy Mcinerney

This profile gathers the share dealings of Timothy Mcinerney across 3 companies, led by Alaunos Therapeutics, Inc., Insite Vision Inc and TG Therapeutics, Inc. Between 30 January 2007 and 28 October 2015, the trades on record add up to 22 filings.

On the market, this insider has only ever bought: 4 purchases, €253k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 14 share grants.

Half of the purchases are above €67k and half below. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 67% of cases, with a median move of +24.3%. These figures describe past trades and do not predict future prices.

Most recently, on 30 October 2015, the filings show a transaction worth €191k in Insite Vision Inc. The clock since the last published purchase (20 July 2011) now reads 5,574 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.